Kim Peder Dalhoff (Kim Dalhoff)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Anti Inflammatory Drugs

Machine Learning

High Throughput

Top Venues

Basic & clinical pharmacology & toxicology

Clinical toxicology (Philadelphia, Pa.)

Acta anaesthesiologica Scandinavica

JMIR mHealth and uHealth

This page only lists publications with an associated author ORCID identifier.

Publications

Morten Baltzer Houlind, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Peder Dalhoff, Per Damkier, Anne B Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic & clinical pharmacology & toxicology (2024)
Philip Ahle Erichsen, Kim Peder Dalhoff, Michael Asger Andersen
Should high-dose N-acetylcysteine be given in cases of massive paracetamol overdoses: A narrative review. Basic & clinical pharmacology & toxicology 135 (3) (2024)
Morten Baltzer Houlind, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Peder Dalhoff, Per Damkier, Anne B Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic & clinical pharmacology & toxicology 134 (5) (2024)
Morten Baltzer Houlind, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Peder Dalhoff, Per Damkier, Anne B Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic & clinical pharmacology & toxicology 134 (5) (2024)
Jonas Henrik Kristensen, Rasmus Bo Hasselbalch, Nina Strandkjær, Nicoline Jørgensen, Morten Østergaard, Hasse Møller Sørensen, Jens Christian Nilsson, Shoaib Afzal, Pia Rørbæk Kamstrup, Morten Dahl, Mustafa Vakur Bor, Ruth Frikke-Schmidt, Niklas Rye Jørgensen, Line Rode, Lene Holmvang, Jesper Kjærgaard, Lia Evi Bang, Julie Lyng Forman, Kim Peder Dalhoff, Allan S Jaffe, Kristian Thygesen, Henning Bundgaard, Kasper Karmark Iversen
Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans. Circulation (2024)
Philip Ahle Erichsen, Kim Peder Dalhoff, Michael Asger Andersen
Should high-dose N-acetylcysteine be given in cases of massive paracetamol overdoses: A narrative review. Basic & clinical pharmacology & toxicology (2024)
Anders Peder Højer Karlsen, Pernille Bjersand Sunde, Markus Harboe Olsen, Jens Laigaard, Caroline Folkersen, Trang Xuan Minh Tran, Ida Houtved Rasmussen, Selma Kjartansdóttir, Atena Saito, Michael Asger Andersen, Mathias Maagaard, Nicholas Papadomanolakis-Pakis, Kim Peder Dalhoff, Lone Nikolajsen, Troels Haxholdt Lunn, Christian Sahlholt Meyhoff, Janus Christian Jakobsen, Ole Mathiesen
Opioids and personalized analgesia in the perioperative setting: A protocol for five systematic reviews. Acta anaesthesiologica Scandinavica (2024)
Thomas Leth Jensen, Matilde Tejlbo Frost, Kim Peder Dalhoff, Tonny Studsgaard Petersen
Repeated poisonings in Denmark - a nationwide study. Clinical toxicology (Philadelphia, Pa.) (2023)
Charlotte Uggerhøj Andersen, Steffen Hansen, Kim Peder Dalhoff, Lars Peter Nielsen, Jørn Munkhof Møller, Anne Estrup Olesen
Clinical characteristics of hospitalized patients with paracetamol poisoning before and after restrictions of over-the-counter sale of paracetamol. Clinical toxicology (Philadelphia, Pa.) (2023)
Astrid Eliasen, Mikkel Kramme Abildtoft, Niels Steen Krogh, Catherine Rechnitzer, Jesper Sune Brok, René Mathiasen, Kjeld Schmiegelow, Kim Peder Dalhoff
Smartphone App to Self-Monitor Nausea During Pediatric Chemotherapy Treatment: User-Centered Design Process. JMIR mHealth and uHealth 8 (7) (2020)